Cancer Conference Update: 2025 ESMO Annual Meeting — Breast Cancer Microlearning Activity 1
Practical Perspectives: Clinical Investigators Review Actual Cases of Patients with HER2-Positive GI Cancers
Featuring a slide presentation and related discussion from Dr Erika Hamilton
Presentation
Exploring the Potential Role of PROTAC Estrogen Receptor Degraders in the Management of HR-Positive mBC (Presentation)
Exploring the Potential Role of PROTAC Estrogen Receptor Degraders in the Management of HR-Positive mBC
Patient Education Resource — Cancer Q&A: The Role and Reality of CAR T-Cell Therapy for Non-Hodgkin Lymphoma
Striving for Consensus: Clinical Investigators Review the Role of Oral SERDs in the Care of Patients with ER-Positive Metastatic Breast Cancer
Practical Perspectives: Clinical Investigators Review Actual Cases of Patients with Endometrial Cancer
5-Minute Journal Club: Current and Future Role of TROP2-Directed ADCs in Non-Small Cell Lung Cancer — Issue 4
Featuring perspectives from Drs Antonarakis, Burstein, Goetz, Lieu, Lunning, McArthur, Nanda, M Smith, S Smith and Strickler
Video EditionAudio Edition
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care
Featuring a slide presentation and related discussion from Prof Patrick Neven
Presentation
Oncology Today with Dr Neil Love: The Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer (Presentation)
Oncology Today with Dr Neil Love: The Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
Featuring a slide presentation and related discussion from Dr John Strickler
Presentation
Oncology Today with Dr Neil Love: Role of Molecular Residual Disease Analysis and Its Relevance in Colorectal Cancer (Presentation)
Oncology Today with Dr Neil Love: Role of Molecular Residual Disease Analysis and Its Relevance in Colorectal Cancer
5-Minute Journal Club: Defining the Current and Future Role of TROP2-Directed ADCs in Breast Cancer — Issue 4
Current and Future Integration of ADCs into the Management of Metastatic Breast Cancer
5-Minute Journal Club: Defining the Future Role of TROP2-Directed Antibody-Drug Conjugates in NSCLC — Issue 3
The Implications of Recent Datasets for the Current and Future Management of NHL
Featuring a slide presentation and related discussion from Dr Eunice S Wang
Presentation
Oncology Today with Dr Neil Love: Key Presentations from the 2025 ASCO Annual Meeting and the EHA 2025 Congress — AML (Lecture)
Oncology Today with Dr Neil Love: Key Presentations from the 2025 ASCO Annual Meeting and the EHA 2025 Congress — AML Edition
Featuring a slide presentation and related discussion from Dr Laura Huppert
Presentation
Oncology Today with Dr Neil Love: Optimizing the Integration of ADCs into the Treatment of HR-Positive and Triple-Negative mBC (Presentation)
Oncology Today with Dr Neil Love: Optimizing the Integration of ADCs into the Treatment of HR-Positive and Triple-Negative mBC
Featuring perspectives from Drs Jeremy Abramson, Jennifer Crombie and Laurie Sehn, moderated by Dr Abramson
Video EditionAudio Edition
Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Care of Patients with Follicular Lymphoma
